Skip to main content
Journal of Tropical Medicine logoLink to Journal of Tropical Medicine
. 2018 Dec 4;2018:5019215. doi: 10.1155/2018/5019215

Regular Antenatal Attendance and Education Influence the Uptake of Intermittent Preventive Treatment of Malaria in Pregnancy: A Cross-Sectional Study at the University Hospital, Kumasi, Ghana

Otchere Addai-Mensah 1,, Max Efui Annani-Akollor 2, Linda Ahenkorah Fondjo 2, Kwadwo Sarbeng 3, Enoch Odame Anto 2, Eddie-Williams Owiredu 1, Shanice Nglokie Arthur 1
PMCID: PMC6304560  PMID: 30631370

Abstract

Background

The World Health Organization (WHO) recommends the use of Insecticide Treated Bed-Nets and Intermittent Preventive Treatment (IPT) with Sulphadoxine-Pyrimethamine (SP) as interventions in curbing malaria during pregnancy. However, increasing evidence shows a gap in coverage where not all pregnant women receive the recommended SP dose. This study evaluated the factors influencing uptake of IPTp-SP among pregnant women in Kumasi, Ghana.

Methodology

This cross-sectional study was conducted among 280 pregnant women attending the Kwame Nkrumah University of Science and Technology Hospital in Kumasi, Ghana. Validated structured questionnaires were administered to obtain sociodemographic, medical/reproductive information, and IPTp-SP uptake among participants. Statistical analyses were performed using IBM SPSS 25.0 statistics.

Results

The mean age of respondents was 29.7±4.9 years. Of the 280 women interviewed, 74.6% attended the antenatal care (ANC) clinic at least four times with only 31.8% completing the recommended doses. Tertiary education [aOR=3.15, 95% CI (0.94 -10.97), and p=0.042] and ≥ 4 ANC visits [aOR=24.6, 95% CI (5.87-103.07), p<0.0001] had statistically significant higher odds of completing the recommended IPTp-SP dose. However, participants employed by the formal sector [aOR=0.28, 95% CI (0.09 - 0.79), p=0.016] and participants with more than four children [aOR=0.14, 95% CI (0.03 - 0.63), and p=0.011] had statistically significant lower odds of completing the recommended IPT dose.

Conclusion

ANC attendance is critical in IPTp uptake. The results emphasize the need for the Health Policy Makers in Kumasi to encourage pregnant women, especially women working in the formal sector and women having more than four children to patronize ANC attendance to ensure high coverage of the recommended IPTp dose.

1. Introduction

Pregnant women as well as the foetus are vulnerable to malaria infection [1], which has been associated with anaemia, maternal death, spontaneous abortions, low birth weight, and neonatal death [2, 3]. While malaria is a preventable and treatable disease, it continues to remain the leading cause of outpatient department (OPD) attendance in Ghana [4, 5]. It is still the most commonly reported disease, accounting for over 55.0% of all OPD attendance [5], 13.7% of admissions among pregnant women, and 3.4% of maternal deaths [6]. The first and second pregnancies are normally the most influenced. The prevalence of parasitaemia is prominent in the second and third trimesters and susceptibility to clinical malaria may persist into the postpartum period [6].

The administration of Sulphadoxine-Pyrimethamine (SP) during ANC visits as recommended by the WHO is to ameliorate the effects of malaria in pregnancy [4, 7]. ANC clinic attendance provides a planned programme for medical management of pregnant women whilst ensuring safe motherhood [812]. A cross-sectional study by Azizi et al. reports an association between the number of ANC visits and use of DOTs with the utilization of at least three doses of SP [13]. Another cross-sectional study involving 18,603 women aged between 15 and 49 years collected from the Malaria Indicator Surveys (MIS) conducted in Burkina Faso, Ghana, Mali, Malawi, Kenya, Nigeria, Sierra Leone, and Uganda showed an overall prevalence of 29.5% for taking three doses of IPTp-SP, with the prevalence being highest for Ghana (60%), followed by Kenya (37%) and Sierra Leone (31%) [14]. The Intermittent Preventive Treatment in pregnancy with SP is a key intervention recommended to reduce maternal malaria episodes, maternal and fetal anaemia, placental parasitaemia, low birth weight, and neonatal mortality among pregnant women living in sub-Saharan Africa [15]. IPT is provided as part of a comprehensive ANC package with other medicines like hematinics and antihelmintics. This provides maximum protection against maternal anaemia and morbidity, as well as low birth weight. It also reduces the risk of spontaneous abortion, stillbirth, and preterm deliveries [3]. The WHO recommendation where, after the first trimester, every pregnant woman should receive the recommended doses of SP at every ANC visit, beginning the first dose at 13-16th weeks of pregnancy, and the next five doses at the 20th, 26th, 30th, 34th, and 38th weeks of gestation [16], under the supervision of a health worker by Directly Observed Therapy (DOT) [15, 17].

With evidence of rise in the number of ANC visits and the adoption of the current IPTp-SP and DOT policy, it is expected that IPTp-SP uptake will be high, thereby reducing the prevalence of malaria in pregnancy and its associated adverse effects [18]. However, in Ghana, pregnant women still present with malaria and maternal anaemia [19, 20]. This study therefore evaluated the factors that influence uptake of IPTp-SP among pregnant women at the Kwame Nkrumah University of Science and Technology Hospital in Kumasi, Ghana.

2. Materials and Methods

2.1. Study Design/Setting

This was a cross-sectional study conducted at the Antenatal Care Unit of the Kwame Nkrumah University of Science and Technology (KNUST) Hospital in Kumasi, Ghana, from January to March, 2016. Kumasi is Ghana's second largest city in Ghana and lies between latitude 6.35°N and 6.40°N and longitude 1.3°W and 1.35°W. It is 150sq km in size and located in the rainforest zone of West Africa with a population of about 2 million inhabitants [21].

The Ashanti region has an intense perennial malaria transmission, with the predominant parasite being P. falciparum. Kumasi recorded the highest number of malaria cases (297,242 cases) in 2011 while the lowest recorded was 217,861 cases (in 2015) [22]. The prevalence of malaria in pregnancy was 36.3% in 2009 [23]. At the KNUST Hospital, the prevalence was 12.6% in 2013 [24].

2.2. Study Population

A total of 280 pregnant women visiting the antenatal unit of the Hospital were recruited for the study. The sample size was calculated using the Raosoft sample size calculator [25]. The minimum sample size required for this study was 196 participants at 95% confidence level, 7% margin of error, and a response distribution of 50%.

2.3. Ethical Considerations

Ethical approval was obtained from the Committee on Human Research Publication and Ethics (CHRPE) of the School of Medical Sciences, Kwame Nkrumah University of Science and Technology (CHPRE/RC/131/16), and the Institutional Review Board of the Kwame Nkrumah University of Science and Technology Hospital. All participants gave their written informed consent after the aim of the study had been explained to them.

2.4. Inclusion and Exclusion Criteria

Pregnant women of all ages who consented after the aim and objectives had been explained to them were recruited for the study. Critically ill-pregnant women were excluded.

2.5. Questionnaire Administration

A well-structured questionnaire was validated and administered to the study participants within the framework of the study variables consisting of demographic information (age, residence, and parity), socioeconomic status (occupation, education, and religion), the awareness of the IPT program, ANC visit, and IPTp-SP doses. Data were collected using an investigator-administered questionnaire in a language that they could easily comprehend.

2.6. Data Analysis

All categorical variables were presented as frequencies (percentages) and continuous variables as Means ± SD. Multivariate logistic regression analysis was used to evaluate the factors that influence ANC visit and completion of the recommended IPTp-SP dose. A p-value < 0.05 was considered statistically significant. All statistical analyses were performed using SPSS version 25.0.

3. Results

Table 1 shows the sociodemographic characteristics and IPTp-SP uptake of the study population

Table 1.

Sociodemographic characteristics and IPTp-SP uptake of the study population.

Variable Frequency (n=280) Percentage (%)
Age (Years) 29.71± 4.9
15-20 4 1.4
21-25 47 16.8
26-30 114 40.7
31-35 77 27.5
36-40 34 12.1
41-45 4 1.4
Educational Status
No education 20 7.1
Primary 124 44.3
Secondary 77 27.5
Tertiary 59 21.0
Religion
Christian 212 75.7
Muslim 68 24.3
Occupation
Unemployed 38 13.6
Informal 171 61.1
Formal 69 24.6
Marital Status
Single 18 6.4
Married 238 85.0
Cohabiting 24 8.6
Parity
0 62 22.1
1 88 31.4
2 72 25.0
3 30 10.7
≥4 28 10.0
IPTp-SPdoses
0 8 2.9
1 108 38.6
2 75 26.8
3 89 31.8

IPTp-SP; intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine.

The mean age of the study population was 29.7 ± 4.9 years. The highest proportion of the participants were 26-30 years old (40.7%), had primary education (44.3%), were Christians (75.7%), employed in the informal sector (61.1%), married (85.0%), and primiparous (31.4%), and took only one IPTp-SP dose (38.6%) (Table 1).

The association between sociodemographic characteristics, medical history, and ANC visits is shown in Table 2. Cohabitation [aOR= 9.2, 95% CI (0.83-101.94)] was associated with increased odds of ANC visits and having three children [aOR = 0.23, 95% CI (0.04-1.19)] was associated with decreased odds of ANC visits, with borderline significance (Table 2).

Table 2.

Association between sociodemographic characteristics, medical history, and ANC visits.

Variable ≤ 3 visits;
71(25.4%)
≥ 4 visits; 209(74.6%) aOR (95% CI) p-value
Age(years)
15-20 0(0) 4(100.0) 1 (reference)
21-25 12(25.5) 35(74.5) 3.02(0.14-63.91) 0.477
26-30 31(27.2) 83(72.8) 2.36(0.13-41.96) 0.557
31-35 17(22.1) 60(77.9) 4.49(0.25-79.03) 0.304
36-40 9(26.5) 25(73.5) 4.05(0.22-73.76) 0.345
41-45 2(50.0) 2(50.0) 1.00(0.06-15.98) 1.000
Education
No education 5(25.0) 15(75.0) 1 (reference)
Primary 36(29.0) 88(70.1) 1.42(0.33-6.06) 0.639
Secondary 16(20.8) 61(79.2) 1.61(0.33-7.89) 0.559
Tertiary 14(23.7) 45(76.3) 1.04(0.14-7.55) 0.971
Religion
Christian 55(25.9) 157(74.1) 1 (reference)
Muslim 16(23.5) 52(76.5) 2.07(0.86-5.00) 0.106
Occupation
Unemployed 4(10.5) 34(89.5) 1 (reference)
Informal 50(28.6) 125(71.4) 0.62(0.19-2.31) 0.518
Formal 17(25.0) 51(75.0) 0.57(0.12-2.63) 0.481
Marital Status
Single 4(22.2) 14(77.8) 1 (reference)
Married 66(27.7) 172(72.3) 2.12(0.38-11.69) 0.389
Cohabiting 1(4.2) 23(95.8) 9.2(0.83-101.94) 0.07
Parity
0 11(17.7) 51(82.3) 1 (reference)
1 21(23.9) 67(76.1) 0.88(0.27-2.97) 0.849
2 18(25.0) 54(75.0) 0.55(0.13-2.21) 0.402
3 9(30.0) 21(70.0) 0.23(0.04-1.19) 0.079
>4 12(42.9) 16(57.1) 0.42(0.080-2.21) 0.307
Supervision(DOT)
Yes 66(24.8) 200(75.2) 1 (reference)
No 5(35.7) 9(64.3) 1.87(0.59-5.89) 0.288

DOT: directly observed therapy. Chi square test was performed to compare categorical variables. Multivariate logistic regression analysis was used to evaluate the effect of sociodemographic characteristics and medical history on ANC visits. p < 0.05 was considered statistically significant (p values of significant variables are in bold print).

Table 3 shows association between sociodemographic characteristics, medical history, and ANC IPT dose completion. The age of the participants, their religion and marital status, and directly observed therapy did not significantly influence the IPT dose completion. Pregnant women with tertiary education [aOR=3.15, 95% CI (0.94 -10.97), and p=0.042] and ≥ 4 ANC visits [aOR=24.6, 95% CI (5.87-103.07), and p<0.0001] had statistically significant higher odds of completing the recommended IPT dose compared to the uneducated and those informed through the clinic respectively. However, participants employed by the formal sector [aOR=0.28, 95% CI (0.09 - 0.79), and p=0.016], being primiparous [aOR=0.33, 95% CI (0.14 - 0.77), p=0.010], and women with more than four children [aOR=0.14, 95% CI (0.03 - 0.63), and p=0.011] had statistically significant lower odds of completing the recommended IPT dose (Table 3).

Table 3.

Association between sociodemographic characteristics, medical history, and ANC IPT dose completion.

Variables Complete;
89(31.8%)
Incomplete;
191(68.2%)
aOR (95% CI) p- value
Age
15-20 3(75.0) 1(25.0) 1 (reference)
21-25 14(29.8) 33(70.2) 0.10 (0.01 - 1.61) 0.105
26-30 35(30.7) 79(69.3) 0.11 (0.01 -1.98) 0.138
31-35 25(32.5) 52(67.5) 0.15 (0.01 - 2.73) 0.202
36-40 11(32.4) 23(67.6) 0.22 (0.01 - 4.09) 0.308
41-45 1(25.0) 3(75.0) 0.23 (0.01 - 10.63) 0.457
Education
Uneducated 4(20.0) 16(80.0) 1 (reference)
Primary 30(24.2) 94(75.8) 1.28 (0.40 – 4.12) 0.682
Secondary 29(37.7) 48(62.3) 2.42 (0.74 – 7.94) 0.188
Tertiary 26(44.1) 33(55.9) 3.15 (0.94 -10.97) 0.042
Religion
Christian 69(32.5) 143(67.5) 1 (reference)
Muslim 20(29.4) 48(70.6) 0.97 (0.48 - 1.98) 0.954
Occupation
Unemployed 18(47.4) 20(52.6) 1 (reference)
Informal 48(27.0) 130(73.0) 0.72 (0.31 - 1.73) 0.469
Formal 23(35.9) 41(64.1) 0.28 (0.09 - 0.79) 0.016
Marital status
Single 7(38.9) 11(61.1) 1 (reference)
Married 74(31.1) 164(68.9) 1.69 (0.49 - 5.76) 0.400
Co-habiting 8(33.3) 16(66.7) 1.38 (0.29 - 6.53) 0.681
Parity
0 30(48.4) 32(51.6) 1 (reference)
1 22(25.0) 66(75.0) 0.33 (0.14 - 0.77) 0.010
2 25(34.7) 47(65.3) 0.52 (0.20 - 1.33) 0.174
3 8(26.7) 22(73.3) 0.34 (0.10 - 1.14) 0.081
≥ 4 4(14.3) 24(85.7) 0.14 (0.03 - 0.63) 0.011
Number of ANC visits
≤ 3 2(2.8) 69(97.2) 1 (reference)
≥ 4 87(41.6) 122(58.4) 24.6(5.87-103.07) <0.0001
Supervision (DOT)
Yes 86(32.3) 180(67.7) (reference)
No 3(21.4) 11(78.6) 1.81 (0.42 - 7.81) 0.425

Complete: completion of recommended dose, ANC: antenatal care, and DOT: directly observed therapy. Multivariate logistic regression analysis was used to evaluate the effect of sociodemographic characteristics and medical history on ANC IPTp-SP dose completion. p < 0.05 was considered statistically significant (p values of significant variables are in bold print).

4. Discussion

ANC attendance and, subsequently, the uptake of intermittent preventive treatment to reduce the prevalence of malaria in pregnancy are expected to improve with the implementation of the current IPTp-SP and DOT policy. Nevertheless, current studies in Ghana show that the prevalence of malaria in pregnancy is still high [26, 27]. At the KNUST Hospital, the prevalence was 12.6% in 2013 [24]. This study therefore evaluated the factors that influence uptake of IPTp-SP among pregnant women at the University Hospital in Kumasi, Ghana.

Most of the respondents were within the child bearing age of 26-30 years, married, and primiparous (Table 1), consistent with an earlier study in Ghana by Doku and coworkers [28].

It was observed from this study that ANC attendance ranged from 2-12 visits with most of the participants (74.6%) making four or more visits (Table 2). This study shows an increased ANC attendance, similar to cross-sectional studies by Gross et al. [29] in Tanzania and Bouyou-Akotet et al., in Gabon [30]. This high attendance rate offers the potential for implementing the nationally recommended approaches to curbing malaria among Ghanaian pregnant women. Additionally, WHO also recommends that, after the first trimester, every pregnant woman should receive the recommended doses of SP at every ANC visit, beginning the first dose at 13-16th weeks of pregnancy and the next five doses at the 20th, 26th, 30th, 34th, and 38th weeks of gestation [16].

Findings from this study also show that cohabiting respondents [aOR= 9.2, 95% CI (0.83-101.94)] were more likely to attend the ANC compared to single women (Table 2). This corroborates a study in South-Eastern Tanzania which reported that marital status is an independent factor that influences the frequency of ANC visits [29]. Furthermore, the same study identified that not being supported by a spouse was a factor associated with a late antenatal care enrollment, buttressing the effect of companionship on ANC attendance [29]. Moreover, a cross-sectional study conducted in Ghana noted that husbands played an economic role in the frequency of a pregnant women's ANC visits with some men taking up the responsibility of maintaining the well-being of their pregnant wives by ensuring that they attend ANC clinics, whiles adolescent pregnant girls are less likely to attend an ANC and seek timely healthcare [31, 32] due to stigmatization and financial constraints.

The World Malaria Report has over the years indicated an improvement in IPT coverage among pregnant women in sub-Saharan Africa, with a recent coverage of 19% in 2016 [18]. According the Demographic Health Survey, Ghana made significant strides in improving IPT uptake from 26.8% in 2008 to 38.5% in 2014 [33, 34]. This current study observed a higher coverage of 31.8% (Table 3). The coverage in this study is lower compared to a recent cross-sectional hospital-based study by Owusu-Boateng, and Anto among Ghanaians [35]. They reported a higher coverage of IPT3 (87.5%), IPT4 (55.7%), and IPT5 (14.5%); a discrepancy that may be attributed to the fact that their study was conducted in the national capital, Accra, where most people are educated and policy implementation is effective compared to our study area. Notwithstanding the higher coverage in this, there is the need for improved IPT administration, as the coverage is far below the targeted coverage of 100% [36].

Anchang-Kimbi et al., in 2014, suggested that late first ANC clinic enrollment and fewer clinic visits may prevent the uptake of SP; however education on early and regular ANC clinic visits may increase IPTp coverage [37]. Other studies have however reported a negative influence of education on ANC visit and IPTp –SP uptake [38, 39]. This study, on the contrary, observed that pregnant women with tertiary level of education [aOR=3.15, 95% CI (0.94 -10.97), and p=0.042] were more likely to complete the recommended IPTp-SP dose in comparison to the uneducated (Table 3), consistent with other studies [4045]. This association may be attributed to the ability of the educated to understand health information as well as its significance and hence adherence to the recommended dose [4648].

However, women who worked in the formal sector [aOR=0.28, 95% CI (0.09 - 0.79), and p=0.016] were less likely to complete recommended SP dose compared to the informally employed (Table 3). This may be attributed to the fact that women employed in the formal sector work under strict conditions and are not at liberty to leave their jobs to attend the antenatal clinics [29].

Our study also shows that primiparous women were less likely to complete the recommended dose of SP [aOR=0.33, 95% CI (0.14 - 0.77), and p=0.010] compared with women with no child (Table 3). This finding is in consonance with reports by Kuile et al, [49] and Olorunda, [50] who indicated that have only one child are less likely to use malaria preventive measures due to their younger age. Moreover, women with more than four children [aOR=0.14, 95% CI (0.03 - 0.63), p=0.011] were also less likely to complete the recommended IPTp-SP dose (Table 3). Furthermore, higher number of ANC visits [aOR=24.6, 95% CI (5.87-103.07), p<0.0001] positively influenced the uptake of the recommended IPT dose (Table 3). This is in consonance with a cross-sectional study by Bouyou-Akotet et al., in 2013 among Gabonese [30], and Nkoka et al. among Malawian women [51]. Nonetheless, the finding of this study contradicts a cross-sectional study by Toure et al. in Côte d'Ivoire [52]; however, SP stock shortage, absence of cups and clean drinking water for taking SP by DOT, unclear guidelines or confusion among health workers regarding the guidelines, and other related health facility factors were the factors attributed to the hindrance of the IPTp delivery.

This study is limited by the fact that some of the responses provided by the participants may not be accurate due to fear of incrimination. However, participants were assured of privacy and confidentiality of the information they provided. Another limitation of this study is that it was done in an urban setting and might not be generalizable to other areas especially rural areas. Furthermore, factors such as availability of drugs at the health facility and health workers' performance that may have influence IPT-SP uptake were not assessed. Moreover, the study area was a large tertiary hospital and women might be from different areas that might differ in malaria endemicity.

5. Conclusion

ANC attendance is critical in IPTp uptake. The results emphasize the need for the Health Policy Makers in Kumasi to encourage pregnant women, especially women working in the formal sector and women having more than four children to patronize ANC attendance to ensure high coverage of the recommended IPTp dose.

Acknowledgments

The authors are grateful to the Head of Department and Staff of the Antenatal Clinic, KNUST, the Laboratory Manager of the KNUST Hospital, and all the pregnant women who participated in the study.

Data Availability

All relevant data are within the article.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors' Contributions

Otchere Addai-Mensah, the PI, designed the study, supervised the research and laboratory analysis, drafted the manuscript, and revised it. Max Efui Annani-Akollor, Linda Ahenkorah Fondjo, Kwadwo Sarbeng, and Shanice Nglokie Arthur were involved in the design of the study, collection of data, laboratory analysis, and drafting and revision of the manuscript. Enoch Odame Anto and Eddie-Williams Owiredu were involved in the design of the study, collection of data, and statistical analysis. All authors read and approved the final manuscript.

References

  • 1.Uneke C. J. Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa. II: effects of placental malaria on perinatal outcome; malaria and HIV. Yale Journal of Biology and Medicine. 2007;80(3):95–103. [PMC free article] [PubMed] [Google Scholar]
  • 2.Ghana Statistical Service (GSS) GHSG. 2014 Demographic and Health Survey - Key Indicators. 2015. [Google Scholar]
  • 3.Rush D. Nutrition and maternal mortality in the developing world. American Journal of Clinical Nutrition. 2000;72(1):212S–240S. doi: 10.1093/ajcn/72.1.212S. [DOI] [PubMed] [Google Scholar]
  • 4.World Health Organization. World Malaria Report, 2014. 2015. [Google Scholar]
  • 5.Gobah F. K., Zhang L. The national health insurance scheme in ghana: prospects and challenges: a cross-sectional evidence. Global Journal of Health Science. 2011;3(2):90–101. doi: 10.5539/gjhs.v3n2p90. [DOI] [Google Scholar]
  • 6.National Malaria Control Programme GHS. Malaria In Pregnancy. 2014, http://www.ghanahealthservice.org/malaria/subcategory.php?nmcpscid=114&amp;nmcpcid=85.
  • 7.World Health Organization. World Malaria Report 2016. Geneva, Switzerland: World Health Organization; 2016. [Google Scholar]
  • 8.Bullough C., Meda N., Makowiecka K., Ronsmans C., Achadi E. L., Hussein J. Current strategies for the reduction of maternal mortality. BJOG: An International Journal of Obstetrics & Gynaecology. 2005;112(9):1180–1188. doi: 10.1111/j.1471-0528.2005.00718.x. [DOI] [PubMed] [Google Scholar]
  • 9.Hill J., Kayentao K., Achieng F., et al. Access and use of interventions to prevent and treat malaria among pregnant women in Kenya and Mali: A qualitative study. PLoS ONE. 2015;10(3) doi: 10.1371/journal.pone.0119848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bereket Y., Mulat T., Mothers W. P. Utilization Of Antenatal Care And Their Satisfaction With Delivery Services In Selected Public Health Facilities Of Wolaita Zone, Southern Ethiopia. International Journal Of Scientific & Technology Research. 2013;2(2):74–85. [Google Scholar]
  • 11.Lincetto O., Mothebesoane-Anoh S., Gomez P., Munjanja S. Opportunities for African Newborns. World Health Organization; 51-62, 2012. [Google Scholar]
  • 12.ACCESS. Academy for Educational Development (AED); Africa’s Health 2010; ACQUIRE/EngenderHealth BIPAIIFoGaOFL. Opportunities for Africa’s Newborns. ACCESS, Academy for Educational Development (AED), Africa’s Health 2010: Cape Town, South Africa; 2010. [Google Scholar]
  • 13.Azizi S. C., Chongwe G., Chipukuma H., Jacobs C., Zgambo J., Michelo C. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study. BMC Pregnancy and Childbirth. 2018;18(1) doi: 10.1186/s12884-018-1744-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yaya S., Uthman O., Amouzou A., Bishwajit G. Use of Intermittent Preventive Treatment among Pregnant Women in Sub-Saharan Africa: Evidence from Malaria Indicator Surveys. Tropical Medicine and Infectious Disease. 2018;3(1):p. 18. doi: 10.3390/tropicalmed3010018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.World Health Organization. Updated WHO Policy Recommendation on Use of IPTp 2012. [Google Scholar]
  • 16.WHO. Implementing malaria in pregnancy programs in the context of World Health Organization recommendations on antenatal care for a positive pregnancy experience. 2018. [Google Scholar]
  • 17.World Health Organization. WHO Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy using Sulfadoxine‐Pyrimethamine (IPTp‐SP) 2013. [Google Scholar]
  • 18.WHO. Malaria: Intermittent preventive treatment in pregnancy (IPTp) 2018. [Google Scholar]
  • 19.Ahenkorah B., Nsiah K., Baffoe P., Anto E. O. Biochemical and hematological changes among anemic and non-anemic pregnant women attending antenatal clinic at the Bolgatanga regional hospital, Ghana. BMC Hematology. 2018;18(1) doi: 10.1186/s12878-018-0121-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Geelhoed D., Agadzi F., Visser L., et al. Maternal and fetal outcome after severe anemia in pregnancy in rural Ghana. Acta Obstetricia et Gynecologica Scandinavica. 2006;85(1):49–55. doi: 10.1080/00016340500334794. [DOI] [PubMed] [Google Scholar]
  • 21. Ghana Statistical Service AR, Ghana, Noguchi Memorial Institute forMedical Research, Legon, Ghana, and ORCmacro, Calverton, Maryland, USA. Ghana demographic health Survey. 2003.
  • 22.Anokye R., Acheampong E., Owusu I., Isaac Obeng E., Lin Y. Time series analysis of malaria in Kumasi: Using ARIMA models to forecast future incidence. Cogent Social Sciences. 2018;4(1) doi: 10.1080/23311886.2018.1461544. [DOI] [Google Scholar]
  • 23.Yatich N. J., Yi J., Agbenyega T., et al. Malaria and intestinal helminth co-infection among pregnant women in Ghana: prevalence and risk factors. The American Journal of Tropical Medicine and Hygiene. 2009;80(6):896–901. doi: 10.4269/ajtmh.2009.80.896. [DOI] [PubMed] [Google Scholar]
  • 24.C. K. Tay S., Agboli E., Abruquah H. H., Walana W. Malaria and Anaemia in Pregnant and Non-Pregnant Women of Child-Bearing Age at the University Hospital, Kumasi, Ghana∗. Open Journal of Medical Microbiology. 2013;03(03):193–200. doi: 10.4236/ojmm.2013.33029. [DOI] [Google Scholar]
  • 25.Shanti R., Potluri M. Sample Size Calculator. Raosoft Inc; 2009. [Google Scholar]
  • 26.Darko A., Prince A., Jonathan E., Berko S., Delphine G., Kwame W. Asymptomatic malaria and its effect on parturients who received intermittent preventive treatment, a cross sectional study of the Bekwai District Ghana. GSC Biological and Pharmaceutical Sciences. 2018;4(2):7–16. [Google Scholar]
  • 27.Ofori M., Quakyi I., Wilson M., Akanmori B. Prevalence of peripheral blood parasitaemia, anaemia and low birth weight among pregnant women in a suburban area in coastal Ghana. The Pan African Medical Journal. 2014;17(1):p. 3. doi: 10.11694/pamj.supp.2014.17.1.3541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Doku D. T., Zankawah M. M., Adu-Gyamfi A. B. Factors influencing dropout rate of intermittent preventive treatment of malaria during pregnancy. BMC Research Notes. 2016;9(1):1–7. doi: 10.1186/s13104-015-1837-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gross K., Alba S., Glass T. R., Schellenberg J. A., Obrist B. Timing of antenatal care for adolescent and adult pregnant women in south-eastern Tanzania. BMC Pregnancy and Childbirth. 2012;12, article 16 doi: 10.1186/1471-2393-12-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Bouyou-Akotet M. K., Mawili-Mboumba D. P., Kombila M. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon. BMC Pregnancy and Childbirth. 2013;13, article 52 doi: 10.1186/1471-2393-13-52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tolhurst R., Nyonator F. K. Looking within the household: Gender roles and responses to malaria in Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2006;100(4):321–326. doi: 10.1016/j.trstmh.2005.05.004. [DOI] [PubMed] [Google Scholar]
  • 32.Mbonye A. K., Neema S., Magnussen P. Preventing malaria in pregnancy: A study of perceptions and policy implications in Mukono district, Uganda. Health Policy and Planning. 2006;21(1):17–26. doi: 10.1093/heapol/czj002. [DOI] [PubMed] [Google Scholar]
  • 33.Odjidja E. N., Kwanin C., Saha M. Low Uptake of Intermittent Preventive Treatment in Ghana; An Examination of Health System Bottlenecks. Health Systems and Policy Research. 2017;4(3) doi: 10.21767/2254-9137.100079. [DOI] [Google Scholar]
  • 34.Survey DH. Demographic Health Survey dataset, USAID. 2014. [Google Scholar]
  • 35.Owusu-Boateng I., Anto F. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana. Malaria Journal. 2017;16(1) doi: 10.1186/s12936-017-1969-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Service GH. National Malaria Control Programme. 2017. [Google Scholar]
  • 37.Anchang-Kimbi J. K., Achidi E. A., Apinjoh T. O., et al. Antenatal care visit attendance, intermittent preventive treatment during pregnancy (IPTp) and malaria parasitaemia at delivery. Malaria Journal. 2014;13(1, article 162) doi: 10.1186/1475-2875-13-162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Pell C., Meñaca A., Were F., et al. Factors affecting antenatal care attendance: results from qualitative studies in Ghana, Kenya and Malawi. PLoS ONE. 2013;8(1) doi: 10.1371/journal.pone.0053747.e53747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Shimaponda-Mataa N. M., Tembo-Mwase E., Gebreslasie M., Mukaratirwa S. Knowledge, attitudes and practices in the control and prevention of malaria in four endemic provinces of Zambia. Southern African Journal of Infectious Diseases. 2016;32(1):29–39. doi: 10.1080/23120053.2016.1205330. [DOI] [Google Scholar]
  • 40.Bruxvoort K., Goodman C., Patrick Kachur S., Schellenberg D. How patients take malaria treatment: A systematic review of the literature on adherence to antimalarial drugs. PLoS ONE. 2014;9(1) doi: 10.1371/journal.pone.0084555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Li S. Factors affecting therapeutic compliance: A review from the patient&rsquo;s perspective. Therapeutics and Clinical Risk Management. 2008;Volume 4:269–286. doi: 10.2147/TCRM.S1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Nyarko S. H., Cobblah A. Sociodemographic determinants of malaria among under-five children in Ghana. Malaria Research and Treatment. 2014;2014 doi: 10.1155/2014/304361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Department of Gender WHG. Gender, Health and Malaria. 2007. [Google Scholar]
  • 44.Sharma A. K., Aggarwal O. P., Chaturvedi S., Bhasin S. K. Is education a determinant of knowledge about malaria among Indian tribal population? Journal of Communicable Diseases. 2003;35(2):109–117. [PubMed] [Google Scholar]
  • 45.Partnership RBM. Fact Sheet on Malaria and the SDGs. Education and Malaria. 2015, http://www.rollbackmalaria.org/wp-content/uploads/2017/08/RBM_Education_Fact_Sheet_170915.pdf:RollBackMAlaria.Org.
  • 46.Eijla A., Ayisi G., Kuile F. Implementation of IPT with SP for control of malaria in Kisumu, Kenya. Malaria Journal. 2002:265–266. [Google Scholar]
  • 47.Kiwuwa M. S., Mufubenga P. Use of antenatal care, maternity services, intermittent presumptive treatment and insecticide treated bed nets by pregnant women in Luwero district, Uganda. Malaria Journal. 2008;7, article no. 44 doi: 10.1186/1475-2875-7-44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ouma P. O., Van Eijk A. M., Hamel M. J., et al. The effect of health care worker training on the use of intermittent preventive treatment for malaria in pregnancy in rural western Kenya. Tropical Medicine & International Health. 2007;12(8):953–961. doi: 10.1111/j.1365-3156.2007.01876.x. [DOI] [PubMed] [Google Scholar]
  • 49.Ter Kuile F. O., Terlouw D. J., Phillips-Howard P. A., et al. Reduction of malaria during pregnancy by permethrin-treated bed nets in an area of intense perennial malaria transmission in western Kenya. The American Journal of Tropical Medicine and Hygiene. 2003;68(4):50–60. doi: 10.4269/ajtmh.2003.68.50. [DOI] [PubMed] [Google Scholar]
  • 50.Olorunda D., Ajayi I., Falade C. Do Frequent Antenatal Care Visits Ensure Access and Adherence to Intermittent Preventive Treatment of Malaria in Pregnancy in an Urban Hospital in South West Nigeria? African Journal of Biomedical Research. 2013;16:153–161. [Google Scholar]
  • 51.Nkoka O., Chuang T., Chen Y. Association between timing and number of antenatal care visits on uptake of intermittent preventive treatment for malaria during pregnancy among Malawian women. Malaria Journal. 2018;17(1) doi: 10.1186/s12936-018-2360-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Toure O. A., Kone P. L., Coulibaly M. A., et al. Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d Ivoire five years after its implementation. Parasites & Vectors. 2014;7(1, article no. 495) doi: 10.1186/s13071-014-0495-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All relevant data are within the article.


Articles from Journal of Tropical Medicine are provided here courtesy of Wiley

RESOURCES